This site is intended for Healthcare Professionals only.

Pharmanovia appoints Nivedita Valentine as VP of Product Innovation

Date:

Share post:

The life cycle management company, Pharmanovia, has appointed Nivedita Valentine as associate vice president of Product Innovation.

Ms Valentine will oversee the company’s product innovation operations and decision-making as Pharmanovia continues to focus efforts on both, identifying new prospects to enhance lifecycle management of its brands through incremental innovation. She will report to interim chief scientific officer Stephen Deacon and help bridge unmet patient needs with the help of novel therapies, originating both from in-house development and through partnerships.

Ms Valentine currently holds  positions on the value-added medicines committee within Medicines for Europe and the International Rare Diseases Research Consortium (IRDiRC) Task Force on Drug Repurposing Guidebook.

Pharmanovia CEO Dr James Burt commented: “Digitalization and utilizing the latest technological innovation are notable areas of acceleration within the pharma industry and Nivedita’s appointment will ensure iconic brands will continue to be improved, supported, and used sustainably.

“I am delighted to welcome Nivedita to Pharmanovia as we continue the next phase of our strategic growth journey.”

Backed by more than fifteen years of leadership experience, Ms Valentine brings deep market knowledge and technical expertise to Pharmanovia’s product innovation division. Previously she has held global senior management positions at Accord Healthcare and Glenmark Pharmaceuticals.

Commenting on her new role, Ms Valentine said: “Pharmanovia is at an incredibly exciting point within its growth journey, rapidly establishing its position as a leader in life cycle management with a strong, innovative pipeline.

“I’m excited to take on this role within such a committed, patient-centered organization with an incredibly talented, like-minded team who constantly seek to identify new ways to enhance the lives of the patients.”

 

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Current Issue December 2023

Related articles

Chelmsford drug dealer operating as ‘unlicensed chemist’ jailed for six years

Police discovered more than 50,000 pills and tablets of varying types at his residence on Wood Street in...

RPS and PDA respond to DHSC consultation on pharmacy supervision: Read here

Supervision by pharmacy technicians at hospital aseptic facilities should be considered in an entirely separate consultation, PDA said....

Over 100 medicines are currently in short supply, warns BGMA

Reducing disruptions to the movement of medicines around the world is “absolutely critical” for maintaining supply resilience in...

Dry cough syrup ‘codeine linctus’ reclassified to a prescription-only medicine

The drug regulator has warned that the use of codeine in recreational drinks can increase the risk of...